| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/24/2002 | CA2415673A1 Tetrazole derivatives |
| 01/24/2002 | CA2415331A1 Beta3 adrenergic agonists |
| 01/24/2002 | CA2415325A1 Preventing airway mucus production by administration of egf-r antagonists |
| 01/24/2002 | CA2415285A1 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds |
| 01/24/2002 | CA2414674A1 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 01/24/2002 | CA2413582A1 Use of a spla2 inhibitor for the treatment of sepsis |
| 01/24/2002 | CA2410898A1 Substrates and assays for .beta.-secretase activity |
| 01/24/2002 | CA2384041A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 01/24/2002 | CA2377666A1 Stem cell reinforcing material |
| 01/23/2002 | EP1174504A1 Apoptosis-associated gene |
| 01/23/2002 | EP1174434A1 Phosphonic acid derivative having inhibitory activity against carboxypeptidase B |
| 01/23/2002 | EP1174431A2 2-Phenyl-substituited Imidazotriazinones as Phoshodiesterase Inhibitors |
| 01/23/2002 | EP1174421A1 3-amidinobenzenesulfonamide derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 01/23/2002 | EP1174151A1 Preventive or therapeutic drugs for various eosinophilia-related diseases containing chymase inhibitors as the active ingredient |
| 01/23/2002 | EP1174149A1 Proliferation inhibitor for androgen-independent tumor |
| 01/23/2002 | EP1174140A1 Skin preparations for external use |
| 01/23/2002 | EP1174135A2 Pharmaceutical composition for use in treatment of diabetes |
| 01/23/2002 | EP1174129A1 Use of a matrix-metalloprotease inhibitor for the treatment of cancer |
| 01/23/2002 | EP1173767A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/23/2002 | EP1173597A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors |
| 01/23/2002 | EP1173590A2 Zymogen activation system |
| 01/23/2002 | EP1173587A1 Dsp-10 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173571A2 Human ion channel proteins |
| 01/23/2002 | EP1173567A2 Tribonectins |
| 01/23/2002 | EP1173566A2 Human membrane-associated proteins |
| 01/23/2002 | EP1173484A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
| 01/23/2002 | EP1173479A1 49 human secreted proteins |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173476A1 Soybean protein nutraceuticals |
| 01/23/2002 | EP1173475A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 01/23/2002 | EP1173472A1 Cyclic hexapeptides having antibiotic activity |
| 01/23/2002 | EP1173468A1 Integrin receptor antagonists |
| 01/23/2002 | EP1173461A1 50 human secreted proteins |
| 01/23/2002 | EP1173441A1 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 01/23/2002 | EP1173440A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 01/23/2002 | EP1173438A1 Substituted imidazoles, their preparation and use |
| 01/23/2002 | EP1173433A1 Cyanopyrroles as progesterone receptor agonists |
| 01/23/2002 | EP1173432A1 Piperidine-indole compounds having 5-ht6 affinity |
| 01/23/2002 | EP1173429A1 Protease inhibitors |
| 01/23/2002 | EP1173427A1 Hydroxamic acid derivative |
| 01/23/2002 | EP1173426A1 Cyclocarbamate derivatives as progesterone receptor modulators |
| 01/23/2002 | EP1173424A1 Pyrimidine compounds |
| 01/23/2002 | EP1173423A1 Benzimidazolones and analogues and their use as progesterone receptor ligands |
| 01/23/2002 | EP1173418A1 Crystalline forms of the sodium salt of 5- chloro -2- methoxy -n- (2- (4-methoxy -3- methyl aminothio carbonylamino sulfonylphenyl) ethyl) benzamide |
| 01/23/2002 | EP1173415A1 Diphenylurea derivatives |
| 01/23/2002 | EP1173413A1 Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
| 01/23/2002 | EP1173408A1 Ppar-(gamma) agonists as agents for the treatment of type ii diabetes |
| 01/23/2002 | EP1173254A2 Novel treatment of neurotraumatic conditions with a raf inhibitor |
| 01/23/2002 | EP1173223A2 Conjugates as therapies for cancers and prostate diseases |
| 01/23/2002 | EP1173217A2 Enhanced delivery of nucleic acid-based drugs |
| 01/23/2002 | EP1173215A1 Over-coated chewing gum formulations |
| 01/23/2002 | EP1173200A1 Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins |
| 01/23/2002 | EP1173192A2 Methods and compositions for targeted drug delivery |
| 01/23/2002 | EP1173187A2 Combined preparations comprising morpholine anthracyclines and anticancer agent |
| 01/23/2002 | EP1173181A2 Compositions comprising phosphodiesterase inhibitors for the treatment of sexual disfunction |
| 01/23/2002 | EP1173180A1 Camptothecin analogs and methods of preparation thereof |
| 01/23/2002 | EP1173178A1 Apomorphine and sildenafil composition |
| 01/23/2002 | EP1173171A1 Novel anticoagulant injectable composition |
| 01/23/2002 | EP1173170A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/23/2002 | EP1173169A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 01/23/2002 | EP1173168A2 Compound for use as a medicament for treatment of disorders involving bronchocontraction |
| 01/23/2002 | EP1173167A1 Treatment of female arousal disorder |
| 01/23/2002 | EP1173162A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions |
| 01/23/2002 | EP1173158A1 Compounds useful in reducing the level of insulin like growth factor-1 (igf-1) in blood |
| 01/23/2002 | EP1173155A1 Gum pad for delivery of medication to mucosal tissues |
| 01/23/2002 | EP1173149A1 Cosmetic and/or dietetic composition comprising a mixture of lycopene and olive leaf extract |
| 01/23/2002 | EP1173145A1 Composition for cosmetic and dermatological skin care |
| 01/23/2002 | EP1173061A1 Compositions and methods for treatment of hyperproliferative diseases |
| 01/23/2002 | EP1090028B1 Unsaturated 14,15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds |
| 01/23/2002 | EP1056856B1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 01/23/2002 | EP1025100B1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
| 01/23/2002 | EP0904269B1 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors |
| 01/23/2002 | EP0854711B1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 01/23/2002 | EP0833826B1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 01/23/2002 | EP0797590B1 Neurotrophic peptides of activity dependent neurotrophic factor |
| 01/23/2002 | EP0687265B1 Heterocyclic compounds and their preparation and use |
| 01/23/2002 | CN1332801A Connective tissue growth factor (CTGF) and methods of use |
| 01/23/2002 | CN1332744A Tricyclic delta 3-piperidines as alpha 2-antagonists |
| 01/23/2002 | CN1332742A Epothilone derivatives and their use as antitumor agents |
| 01/23/2002 | CN1332741A Pyrazolopyridine derivatives as selective COX-2 inhibitors |
| 01/23/2002 | CN1332740A 5HT antagonists for antidepressant therapy |
| 01/23/2002 | CN1332737A Thrombin inhibitors |
| 01/23/2002 | CN1332734A Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity |
| 01/23/2002 | CN1332731A Substituted benzimidazoles and their prep. and use |
| 01/23/2002 | CN1332729A 4-oxo-1,4-dihybro-3-quinolinecarboxamides as antiviral agents |
| 01/23/2002 | CN1332723A Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 01/23/2002 | CN1332648A Method of providing cosmetic/medical therapy |
| 01/23/2002 | CN1332240A Superoxide dismutase-4 |
| 01/23/2002 | CN1332175A Jackfruit cycloalkane triterpenic saponin as one new compound and its application in the treatment of cardiovascular disease |
| 01/23/2002 | CN1332168A 3-substituted pyrido-[4',3':4,5] thieno-[2,3-d] pyrimidine derivatives, their prep. and use |
| 01/23/2002 | CN1332167A Eprosartan dihydrate and its prep. |
| 01/23/2002 | CN1331920A Oral composition with cardiovascular health and senility delaying functions |
| 01/23/2002 | CN1078208C Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonists |
| 01/23/2002 | CN1078079C Process for preparing Chinese medicine for treating gynopathy |
| 01/23/2002 | CN1078073C Use of bisphophonates in bone-inhibiting reabsorption after transplantation of orthopedic prosthesis |
| 01/23/2002 | CN1078070C Use of benzo-thiophone derivative in prep. of thrombin-inhibiting medicine |
| 01/22/2002 | US6340761 Amination and dehydrohalogenation with piperidine compounds |
| 01/22/2002 | US6340754 Phosphorus containing cyclic nucleotides |
| 01/22/2002 | US6340701 Taxanes chemically linked to cell binding agent for delivering to specific cell population in targeted fashion |
| 01/22/2002 | US6340700 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |